Edwards Lifesciences Corp [NYSE: EW] gained 0.15% on the last trading session, reaching $75.2 price per share at the time.
Edwards Lifesciences Corp represents 587.90 million in outstanding shares, while the company has a total market value of $44.15 billion with the latest information. EW stock price has been found in the range of $74.79 to $76.42.
If compared to the average trading volume of 4.23M shares, EW reached a trading volume of 4844926 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Edwards Lifesciences Corp [EW]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $88.46 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 2.06. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 29, 2025. The new note on the price target was released on April 24, 2025, representing the official price target for Edwards Lifesciences Corp stock. Previously, the target price had yet another raise from $75 to $90, while Stifel kept a Buy rating on EW stock.
The Price to Book ratio for the last quarter was 4.19, with the Price to Cash per share for the same quarter was set at 6.92. Price to Free Cash Flow for EW in the course of the last twelve months was 75.10 with Quick ratio for the last quarter at 3.87.
Trading performance analysis for EW stock
Edwards Lifesciences Corp [EW] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.93. With this latest performance, EW shares dropped by -3.96% in over the last four-week period, additionally plugging by 6.91% over the last 6 months – not to mention a rise of 1.58% in the past year of trading.
Edwards Lifesciences Corp [EW]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Edwards Lifesciences Corp [EW] shares currently have an operating margin of 27.20% and a Gross Margin at 78.13%. Edwards Lifesciences Corp’s Net Margin is presently recorded at 15.11%.
Edwards Lifesciences Corp (EW) Capital Structure & Debt Analysis
According to recent financial data for Edwards Lifesciences Corp. ( EW), the Return on Equity (ROE) stands at 15.71%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 11.98%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Edwards Lifesciences Corp’s Return on Invested Capital (ROIC) is 7.66%, showcasing its effectiveness in deploying capital for earnings.
Edwards Lifesciences Corp (EW) Efficiency & Liquidity Metrics
Based on Edwards Lifesciences Corp’s (EW) latest financial statements, the Debt-to-Equity Ratio is 0.07%, indicating its reliance on debt financing relative to shareholder equity.
Edwards Lifesciences Corp (EW) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Edwards Lifesciences Corp. (EW) effectively leverages its workforce, generating an average of $54379.75 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.68% and a Quick Ratio of 3.87%, indicating strong ability to cover short-term liabilities.
Edwards Lifesciences Corp [EW]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Edwards Lifesciences Corp posted 0.67/share EPS, while the average EPS was predicted by analysts to be reported at 0.59/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.08. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 9.03%.
An analysis of Institutional ownership at Edwards Lifesciences Corp [EW]
There are presently around $88.34%, or 89.15%% of EW stock, in the hands of institutional investors. The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 53.58 million shares, which is approximately 8.8982%. BLACKROCK INC., holding 50.98 million shares of the stock with an approximate value of $$4.71 billion in EW stocks shares; and BLACKROCK INC., currently with $$2.4 billion in EW stock with ownership which is approximately 4.3197%.
